The impact of hepatitis C virus coinfection on HIV progression before and after highly active antiretroviral therapy.

PubWeight™: 1.24‹?› | Rank: Top 10%

🔗 View Article (PMID 12843748)

Published in J Acquir Immune Defic Syndr on July 01, 2003

Authors

Marina B Klein1, Richard G Lalonde, Samy Suissa

Author Affiliations

1: Division of Infectious Diseases/Immunodeficiency, Department of Medicine, Royal Victoria Hospital, McGill University Health Centre, Montreal, Quebec, Canada. marina.klein@muhc.mcgill.ca

Articles citing this

Meta-analysis: increased mortality associated with hepatitis C in HIV-infected persons is unrelated to HIV disease progression. Clin Infect Dis (2009) 2.01

Hepatitis C: a review for primary care physicians. CMAJ (2006) 1.60

Measures of site resourcing predict virologic suppression, immunologic response and HIV disease progression following highly active antiretroviral therapy (HAART) in the TREAT Asia HIV Observational Database (TAHOD). HIV Med (2010) 1.28

Community-based survey of HCV and HIV coinfection in injection drug abusers in Sichuan Province of China. World J Gastroenterol (2004) 1.16

Prevalence and incidence of HCV infection among Vietnam heroin users with recent onset of injection. J Urban Health (2010) 1.12

Hepatitis C and the risk of kidney disease and mortality in veterans with HIV. J Acquir Immune Defic Syndr (2010) 1.01

Chronic hepatitis B and C co-infection increased all-cause mortality in HAART-naive HIV patients in Northern Thailand. Epidemiol Infect (2012) 0.90

Morbidity and mortality profile of human immunodeficiency virus-infected patients with and without hepatitis C co-infection. Am J Trop Med Hyg (2006) 0.90

Prevalence and characteristics of hepatitis B and C virus infections in treatment-naïve HIV-infected patients. Med Microbiol Immunol (2010) 0.88

Relationship between hepatitis C virus (HCV) and insulin resistance, endothelial perturbation, and platelet activation in HIV-HCV-coinfected patients under highly active antiretroviral treatment. Eur J Clin Microbiol Infect Dis (2006) 0.86

Effect of serostatus for hepatitis C virus on mortality among antiretrovirally naive HIV-positive patients. CMAJ (2005) 0.86

Impact of hepatitis C on HIV progression in adults with alcohol problems. Alcohol Clin Exp Res (2007) 0.82

Pegylated interferon alpha-2a with or without ribavirin in HCV/HIV coinfection: partially blinded, randomized multicenter trial. Dig Dis Sci (2005) 0.80

Will a quadruple multiplexed point-of-care screening strategy for HIV-related co-infections be feasible and impact detection of new co-infections in at-risk populations? Results from cross-sectional studies. BMJ Open (2014) 0.80

Interleukin 10 responses are associated with sustained CD4 T-cell counts in treated HIV infection. J Infect Dis (2012) 0.78

HCV coinfection associated with slower disease progression in HIV-infected former plasma donors naïve to ART. PLoS One (2008) 0.78

The Impact of HCV Infection Duration on HIV Disease Progression and Response to cART amongst HIV Seroconverters in the UK. PLoS One (2015) 0.75

HIV/HCV coinfection: management update. J Natl Med Assoc (2004) 0.75

Acute Kidney Dysfunction in Patients with Chronic Hepatitis C Virus Infection: Analysis of Viral and Non-viral Factors. J Clin Exp Hepatol (2014) 0.75

Impact of Hepatitis C Virus on the Circulating Levels of IL-7 in HIV-1 Coinfected Women. J Acquir Immune Defic Syndr (2016) 0.75

Triple positivity of HBsAg, anti-HCV antibody, and HIV and their influence on CD4+ lymphocyte levels in the highly HIV infected population of Abeokuta, Nigeria. Afr Health Sci (2015) 0.75

Articles by these authors

(truncated to the top 100)

Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease. JAMA (2005) 6.87

Renal and retinal effects of enalapril and losartan in type 1 diabetes. N Engl J Med (2009) 6.75

Dopamine agonists and the risk of cardiac-valve regurgitation. N Engl J Med (2007) 6.23

Concurrent use of diuretics, angiotensin converting enzyme inhibitors, and angiotensin receptor blockers with non-steroidal anti-inflammatory drugs and risk of acute kidney injury: nested case-control study. BMJ (2013) 5.33

Use of statins and the risk of death in patients with prostate cancer. J Clin Oncol (2013) 5.28

Inhaled corticosteroid use in chronic obstructive pulmonary disease and the risk of hospitalization for pneumonia. Am J Respir Crit Care Med (2007) 3.94

The use of pioglitazone and the risk of bladder cancer in people with type 2 diabetes: nested case-control study. BMJ (2012) 3.82

Long-term use of antidepressants for depressive disorders and the risk of diabetes mellitus. Am J Psychiatry (2009) 3.33

Progressive loss of echinocandin activity following prolonged use for treatment of Candida albicans oesophagitis. J Antimicrob Chemother (2006) 3.27

Proton pump inhibitor use and risk of community-acquired Clostridium difficile-associated disease defined by prescription for oral vancomycin therapy. CMAJ (2006) 3.18

Androgen deprivation therapy and risk of acute kidney injury in patients with prostate cancer. JAMA (2013) 3.16

Problem of immortal time bias in cohort studies: example using statins for preventing progression of diabetes. BMJ (2010) 3.09

A meta-analysis of the incidence of malignancy in adult patients with rheumatoid arthritis. Arthritis Res Ther (2008) 2.87

Hepatitis B vaccine and the risk of CNS inflammatory demyelination in childhood. Neurology (2008) 2.87

Bronchodilator use and the risk of arrhythmia in COPD: part 1: Saskatchewan cohort study. Chest (2012) 2.65

ACE-I and ARBs in early diabetic nephropathy. J Renin Angiotensin Aldosterone Syst (2002) 2.64

The risk of hospitalized infection in patients with rheumatoid arthritis. J Rheumatol (2008) 2.60

Use of venlafaxine compared with other antidepressants and the risk of sudden cardiac death or near death: a nested case-control study. BMJ (2010) 2.40

Use of first- and second-generation cyclooxygenase-2-selective nonsteroidal antiinflammatory drugs and risk of acute myocardial infarction. Circulation (2006) 2.34

Antirheumatic drugs and the risk of tuberculosis. Clin Infect Dis (2006) 2.29

Fluoroquinolones and the risk of serious arrhythmia: a population-based study. Clin Infect Dis (2012) 2.17

The risk of herpes zoster in patients with rheumatoid arthritis in the United States and the United Kingdom. Arthritis Rheum (2007) 2.16

Didanosine, interferon-alfa and ribavirin: a highly synergistic combination with potential activity against HIV-1 and hepatitis C virus. AIDS (2003) 2.11

Drug drug interactions between antithrombotic medications and the risk of gastrointestinal bleeding. CMAJ (2007) 2.02

Cardiovascular morbidity and mortality in COPD. Chest (2005) 2.01

Benzodiazepines and elderly drivers: a comparison of pharmacoepidemiological study designs. Pharmacoepidemiol Drug Saf (2007) 1.98

Hepatitis B vaccination and the risk of childhood-onset multiple sclerosis. Arch Pediatr Adolesc Med (2007) 1.96

Discontinuation of statin therapy following an acute myocardial infarction: a population-based study. Eur Heart J (2008) 1.94

Patterns of antibiotic use and risk of hospital admission because of Clostridium difficile infection. CMAJ (2008) 1.91

Natural history of multiple sclerosis with childhood onset. N Engl J Med (2007) 1.89

The nested case-control study in cardiology. Am Heart J (2003) 1.84

Gender differences in survival following hospitalisation for COPD. Thorax (2010) 1.73

The early natural history of nephropathy in Type 1 Diabetes: III. Predictors of 5-year urinary albumin excretion rate patterns in initially normoalbuminuric patients. Diabetes (2005) 1.67

The use of inhaled corticosteroids and the risk of adrenal insufficiency. Eur Respir J (2012) 1.67

The concurrent use of antithrombotic therapies and the risk of bleeding in patients with atrial fibrillation. Thromb Haemost (2013) 1.53

Acute disseminated encephalomyelitis cohort study: prognostic factors for relapse. Eur J Paediatr Neurol (2006) 1.49

First episode of acute CNS inflammatory demyelination in childhood: prognostic factors for multiple sclerosis and disability. J Pediatr (2004) 1.48

The utility of the Health Plan Employer Data and Information Set (HEDIS) asthma measure to predict asthma-related outcomes. Ann Allergy Asthma Immunol (2004) 1.44

Use of lithium and the risk of injurious motor vehicle crash in elderly adults: case-control study nested within a cohort. BMJ (2004) 1.44

Immediate and delayed impact of oral glucocorticoid therapy on risk of serious infection in older patients with rheumatoid arthritis: a nested case-control analysis. Ann Rheum Dis (2012) 1.43

The use of metformin and the incidence of lung cancer in patients with type 2 diabetes. Diabetes Care (2012) 1.42

Bronchodilator use and the risk of arrhythmia in COPD: part 2: reassessment in the larger Quebec cohort. Chest (2012) 1.42

The relationship of diabetic retinopathy to preclinical diabetic glomerulopathy lesions in type 1 diabetic patients: the Renin-Angiotensin System Study. Diabetes (2005) 1.40

Metformin and the incidence of prostate cancer in patients with type 2 diabetes. Cancer Epidemiol Biomarkers Prev (2010) 1.39

Antibiotics in primary prevention of stroke in the elderly. Stroke (2003) 1.39

Cyclooxygenase-2 selective nonsteroidal anti-inflammatory drugs and the risk of ischemic stroke: a nested case-control study. Stroke (2006) 1.38

Androgen-deprivation therapy and the risk of stroke in patients with prostate cancer. Eur Urol (2011) 1.37

Point: were industry-sponsored roflumilast trials appropriate? Yes. Chest (2014) 1.36

Impact of HIV-1 viral subtype on CD4+ T-cell decline and clinical outcomes in antiretroviral naive patients receiving universal healthcare. AIDS (2009) 1.32

Transdermal and oral hormone replacement therapy and the risk of stroke: a nested case-control study. BMJ (2010) 1.32

MRI prognostic factors for relapse after acute CNS inflammatory demyelination in childhood. Brain (2004) 1.31

Evaluating liver fibrosis progression and the impact of antiretroviral therapy in HIV and hepatitis C coinfection using a noninvasive marker. J Acquir Immune Defic Syndr (2007) 1.28

Incretin based drugs and risk of acute pancreatitis in patients with type 2 diabetes: cohort study. BMJ (2014) 1.27

Nonsteroidal anti-inflammatory drug use and the risk of severe skin and soft tissue complications in patients with varicella or zoster disease. Br J Clin Pharmacol (2008) 1.23

Incidence of and mortality from venous thromboembolism in a real-world population: the Q-VTE Study Cohort. Am J Med (2013) 1.22

The case-crossover study design in pharmacoepidemiology. Stat Methods Med Res (2008) 1.21

Association Between Incretin-Based Drugs and the Risk of Acute Pancreatitis. JAMA Intern Med (2016) 1.21

Trends in the prescription of anti-diabetic medications in the United Kingdom: a population-based analysis. Pharmacoepidemiol Drug Saf (2009) 1.19

Mortality after infection with methicillin-resistant Staphylococcus aureus (MRSA) diagnosed in the community. BMC Med (2008) 1.18

Re: Helene Hartvedt Grytli, Morten Wang Fagerland, Sophie D. Fosså, Kristin Austlid Taskén. Association between use of β-blockers and prostate cancer-specific survival: a cohort study of 3561 prostate cancer patients with high-risk or metastatic disease. Eur Urol (2013) 1.13

Lifestyle variables and the risk of myocardial infarction in the general practice research database. BMC Cardiovasc Disord (2007) 1.12

Risks of pneumonia in patients with asthma taking inhaled corticosteroids. Am J Respir Crit Care Med (2010) 1.12

Rheumatoid arthritis, its treatments, and the risk of tuberculosis in Quebec, Canada. Arthritis Rheum (2009) 1.10

Hematologic malignant neoplasms after drug exposure in rheumatoid arthritis. Arch Intern Med (2008) 1.09

Re: Daniel E. Spratt, Chi Zhang, Zachary S. Zumsteg, Xin Pei, Zhigang Zhang, Michael J. Zelefsky. Metformin and prostate cancer: reduced development of castration-resistant disease and prostate cancer mortality. Eur Urol 2013;63:709-16. Eur Urol (2013) 1.09

Secular trends of antibacterial prescribing in UK paediatric primary care. J Antimicrob Chemother (2010) 1.08

Body mass index (BMI) and waist circumference (WC) as screening tools for cardiovascular risk factors in Guadeloupean women. J Clin Epidemiol (2002) 1.06

Antimicrobial drugs and community-acquired Clostridium difficile-associated disease, UK. Emerg Infect Dis (2007) 1.06

The association between systemic glucocorticoid therapy and the risk of infection in patients with rheumatoid arthritis: systematic review and meta-analyses. Arthritis Res Ther (2011) 1.04

Gastro-intestinal haemorrhage risks of selective serotonin receptor antagonist therapy: a new look. Br J Clin Pharmacol (2008) 1.02

Parental smoking at home and the risk of childhood-onset multiple sclerosis in children. Brain (2007) 1.01

Demyelinating events in rheumatoid arthritis after drug exposures. Ann Rheum Dis (2009) 1.00

Estrogen therapy and risk of cognitive decline: results from the Women's Estrogen for Stroke Trial (WEST). Am J Obstet Gynecol (2005) 1.00

Warfarin use and the risk of motor vehicle crash in older drivers. Br J Clin Pharmacol (2006) 1.00

Effects of duration and age at onset of type 1 diabetes on preclinical manifestations of nephropathy. Diabetes (2003) 0.99

Anti-diabetic drug use and the risk of motor vehicle crash in the elderly. Can J Clin Pharmacol (2006) 0.98

Exclusion of immortal person-time. Pharmacoepidemiol Drug Saf (2008) 0.98

Prognosis of pulmonary arterial hypertension: the power of clinical registries of rare diseases. Circulation (2010) 0.98

Infections requiring hospitalization in the abatacept clinical development program: an epidemiological assessment. Arthritis Res Ther (2010) 0.97

Combined oral contraceptive use and the risk of systemic lupus erythematosus. Arthritis Rheum (2009) 0.96

Simvastatin in moderate-to-severe COPD. N Engl J Med (2014) 0.96

The relation of ambulatory blood pressure and pulse rate to retinopathy in type 1 diabetes mellitus: the renin-angiotensin system study. Ophthalmology (2006) 0.96

Epidemiology of inflammatory bowel disease in Québec: recent trends. Inflamm Bowel Dis (2014) 0.96

Antimicrobial drugs and community-acquired methicillin-resistant Staphylococcus aureus, United Kingdom. Emerg Infect Dis (2007) 0.95

Long-term use of antihypertensive drugs and risk of cancer. Pharmacoepidemiol Drug Saf (2008) 0.95

Hormone therapy administration in postmenopausal women and risk of stroke. Womens Health (Lond Engl) (2011) 0.94

Inhaled corticosteroids and risk of tuberculosis in patients with respiratory diseases. Am J Respir Crit Care Med (2010) 0.94

Oral corticosteroid use and the risk of acute myocardial infarction in chronic obstructive pulmonary disease. Can Respir J (2006) 0.93

Risk of injurious road traffic crash after prescription of antidepressants. J Clin Psychiatry (2012) 0.93

Avoiding common pitfalls in the analysis of observational studies of new treatments for rheumatoid arthritis. Arthritis Care Res (Hoboken) (2010) 0.93

Medications to modify lung function decline in chronic obstructive pulmonary disease: some hopeful signs. Am J Respir Crit Care Med (2008) 0.93

Calculation of number needed to treat. N Engl J Med (2009) 0.92

Hormone replacement therapy use and the risk of stroke. Maturitas (2008) 0.91

Letter by Azoulay and Suissa regarding article, "statins and the risk of cancer after heart transplantation". Circulation (2013) 0.91

Prognostic factors for early severity in a childhood multiple sclerosis cohort. Pediatrics (2006) 0.90

The impact of over-the-counter simvastatin on the number of statin prescriptions in the United Kingdom: a view from the General Practice Research Database. Pharmacoepidemiol Drug Saf (2007) 0.90

Traditional versus marginal structural models to estimate the effectiveness of beta-blocker use on mortality after myocardial infarction. Pharmacoepidemiol Drug Saf (2009) 0.89

Validating the effects of drug treatment on blood pressure in the General Practice Research Database. Pharmacoepidemiol Drug Saf (2008) 0.89

Short-acting inhaled beta-2-agonists increased the mortality from chronic obstructive pulmonary disease in observational designs. J Clin Epidemiol (2005) 0.89

Long-term use of angiotensin receptor blockers and the risk of cancer. PLoS One (2012) 0.89